Bb Biotech Ag(XSWX) BION

Market CapCHF 2.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)+1,358%
5 Year-40%
1 Year+28%
1 Month-7%
CHF 48.90
-1.21%
-0.60Today
Bb Biotech Ag last closing stock price
MetricPriceDate
Last closeCHF 48.902026-10-13
Bb Biotech Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.51%CHF 49.652026-10-06
1 month-6.86%CHF 52.502026-09-11
3 month-1.81%CHF 49.802026-07-15
Year to date+8.79%CHF 44.952025-12-30
1 year+28.18%CHF 38.152025-10-13
3 year+23.95%CHF 39.452023-10-13
5 year-40.11%CHF 81.652021-10-14
Since inception+1,357.65%CHF 3.351997-11-27

Bb Biotech Ag Financials at a Glance

Market Cap

CHF 2.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 146.00

Net Income (TTM)

CHF 1.35K

EPS (TTM)

CHF 24.51

P/E Ratio

2.00

Dividend

CHF 2.25

Beta (Volatility)

0.03 (Low)

Price

CHF 48.90

Volume

56,877

Open

CHF 49.40

Previous Close

CHF 49.50

Daily Range

CHF 48.85 - CHF 49.70

52-Week Range

CHF 37.25 - CHF 57.00

Estimated Earnings Date

N/A

BION News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bb Biotech Ag

BB Biotech is an equity fund launched and managed by Bellevue Asset Management. It invests in the public equity markets across the globe. BB Biotech primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. It employs a fundamental analysis to create its portfolio. BB Biotech began operation on November 09, 1993. It has its headquarters in Schaffhausen in Switzerland.

Industry

Capital Markets

Sector

Financials

Employees

72.8

Website

www.bbbiotech.com

BION Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

54.76%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

50.00%

Dividend Yield

4.60%

Payout Ratio

N/A

Stock Overview

Market Cap

CHF 2.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

55.15M

Volume

56.88K

Avg. Volume

77.80K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bb Biotech Ag Performance Analysis

Bb Biotech Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF -28,350,000N/A
20232023-12-31CHF -17,264,000-39.1%
20242024-12-31CHF 62,133,000N/A
20252025-12-31CHF 76,812,00023.6%
Bb Biotech Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF -6.50-11.0%
20232023-12-31CHF -3.77-42.1%
20242024-12-31CHF 1.38N/A
20252025-12-31CHF 10.54661.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 110.03

-5.4%

Gross Profit

CHF 95.59

N/A

Gross Margin

99.94%

N/A

Market Cap

CHF 2.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CHF 34.05

N/A

Employees

72.8

N/A

Net Income

CHF 451.17

-4.5%

EBITDA

CHF 451.52

-4.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 203.76

+9342.1%

Total Debt

CHF 0.00

N/A

Accounts Receivable

N/A

N/A

Inventory

CHF 0.00

N/A

Long Term Debt

CHF 0.00

N/A

Short Term Debt

CHF 0.00

N/A

Return on Assets

54.68%

-2.8%

Return on Invested Capital

-2.08%

+0.8%

Free Cash Flow

-CHF 150.88

+2.5%

Operating Cash Flow

-CHF 150.88

+2.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,803.85-0.00%
^DJIDJI
$51,687.96-0.00%
^IXICNASDAQ
$27,201.84-0.00%
BTCBitcoin
$83,069.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About BION

What is the current price of Bb Biotech Ag?

Bb Biotech Ag is trading at CHF 48.90 per share.

What is the 52-week range for Bb Biotech Ag?

Over the past 52 weeks, Bb Biotech Ag has traded between CHF 37.25 and CHF 57.00.

How much debt does Bb Biotech Ag have?

As of the most recent reporting period, Bb Biotech Ag reported total debt of CHF 0.00.

How much cash does Bb Biotech Ag have on hand?

Bb Biotech Ag reported CHF 203.76M in cash and cash equivalents in its most recent financial results.

What is Bb Biotech Ag’s dividend yield?

Bb Biotech Ag currently has a dividend yield of 4.60%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services